Cite
Horie Y, Yamazaki K, Funakoshi T, et al. Predictability of antitumor efficacy of cetuximab plus irinotecan based on skin rash severity according to observation period in patients with metastatic colorectal cancer following failure of fluorouracil, irinotecan and oxaliplatin. Mol Clin Oncol. 2015;3(5):1029-1034doi: 10.3892/mco.2015.586.
Horie, Y., Yamazaki, K., Funakoshi, T., Hamauchi, S., Taniguchi, H., Tsushima, T., Todaka, A., Machida, N., Taku, K., Fukutomi, A., Onozawa, Y., Yasui, H., Mizukami, T., Izawa, N., Hirakawa, M., Tsuda, T., Nakajima, T., & Boku, N. (2015). Predictability of antitumor efficacy of cetuximab plus irinotecan based on skin rash severity according to observation period in patients with metastatic colorectal cancer following failure of fluorouracil, irinotecan and oxaliplatin. Molecular and clinical oncology, 3(5), 1029-1034. https://doi.org/10.3892/mco.2015.586
Horie, Yoshiki, et al. "Predictability of antitumor efficacy of cetuximab plus irinotecan based on skin rash severity according to observation period in patients with metastatic colorectal cancer following failure of fluorouracil, irinotecan and oxaliplatin." Molecular and clinical oncology vol. 3,5 (2015): 1029-1034. doi: https://doi.org/10.3892/mco.2015.586
Horie Y, Yamazaki K, Funakoshi T, Hamauchi S, Taniguchi H, Tsushima T, Todaka A, Machida N, Taku K, Fukutomi A, Onozawa Y, Yasui H, Mizukami T, Izawa N, Hirakawa M, Tsuda T, Nakajima T, Boku N. Predictability of antitumor efficacy of cetuximab plus irinotecan based on skin rash severity according to observation period in patients with metastatic colorectal cancer following failure of fluorouracil, irinotecan and oxaliplatin. Mol Clin Oncol. 2015 Sep;3(5):1029-1034. doi: 10.3892/mco.2015.586. Epub 2015 Jun 24. PMID: 26623045; PMCID: PMC4534823.
Copy
Download .nbib